Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review

Pityriasis rosea (PR) is a self-limited disease with exanthematous papulosquamous rashes mostly associated with reactivation of human herpesvirus (HHV)-6 or HHV-7. PR-like eruptions, which occur along with peripheral eosinophilia, interface dermatitis, and eosinophils on histopathology, may result f...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chii-Shyan, Chen, Hsuan-Hsiang, Liu, Shih-Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Formosan Medical Association. Published by Elsevier Taiwan LLC. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8731224/
https://www.ncbi.nlm.nih.gov/pubmed/35012825
http://dx.doi.org/10.1016/j.jfma.2021.12.028
_version_ 1784627313459068928
author Wang, Chii-Shyan
Chen, Hsuan-Hsiang
Liu, Shih-Hao
author_facet Wang, Chii-Shyan
Chen, Hsuan-Hsiang
Liu, Shih-Hao
author_sort Wang, Chii-Shyan
collection PubMed
description Pityriasis rosea (PR) is a self-limited disease with exanthematous papulosquamous rashes mostly associated with reactivation of human herpesvirus (HHV)-6 or HHV-7. PR-like eruptions, which occur along with peripheral eosinophilia, interface dermatitis, and eosinophils on histopathology, may result from medications or vaccinations. Previously, PR-like eruptions had been noted following vaccination for influenza or other vaccines. During this pandemic, acute COVID-19 infection has been related to PR or PR-like eruptions in several cases. Various COVID-19 vaccines associated with PR-like eruptions were rarely reported. Herein, we report a case of cutaneous PR-like eruptions following COVID-19 mRNA-1273 vaccination.
format Online
Article
Text
id pubmed-8731224
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Formosan Medical Association. Published by Elsevier Taiwan LLC.
record_format MEDLINE/PubMed
spelling pubmed-87312242022-01-06 Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review Wang, Chii-Shyan Chen, Hsuan-Hsiang Liu, Shih-Hao J Formos Med Assoc Case Report Pityriasis rosea (PR) is a self-limited disease with exanthematous papulosquamous rashes mostly associated with reactivation of human herpesvirus (HHV)-6 or HHV-7. PR-like eruptions, which occur along with peripheral eosinophilia, interface dermatitis, and eosinophils on histopathology, may result from medications or vaccinations. Previously, PR-like eruptions had been noted following vaccination for influenza or other vaccines. During this pandemic, acute COVID-19 infection has been related to PR or PR-like eruptions in several cases. Various COVID-19 vaccines associated with PR-like eruptions were rarely reported. Herein, we report a case of cutaneous PR-like eruptions following COVID-19 mRNA-1273 vaccination. Formosan Medical Association. Published by Elsevier Taiwan LLC. 2022-05 2022-01-05 /pmc/articles/PMC8731224/ /pubmed/35012825 http://dx.doi.org/10.1016/j.jfma.2021.12.028 Text en © 2022 Formosan Medical Association. Published by Elsevier Taiwan LLC. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Case Report
Wang, Chii-Shyan
Chen, Hsuan-Hsiang
Liu, Shih-Hao
Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review
title Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review
title_full Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review
title_fullStr Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review
title_full_unstemmed Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review
title_short Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review
title_sort pityriasis rosea-like eruptions following covid-19 mrna-1273 vaccination: a case report and literature review
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8731224/
https://www.ncbi.nlm.nih.gov/pubmed/35012825
http://dx.doi.org/10.1016/j.jfma.2021.12.028
work_keys_str_mv AT wangchiishyan pityriasisrosealikeeruptionsfollowingcovid19mrna1273vaccinationacasereportandliteraturereview
AT chenhsuanhsiang pityriasisrosealikeeruptionsfollowingcovid19mrna1273vaccinationacasereportandliteraturereview
AT liushihhao pityriasisrosealikeeruptionsfollowingcovid19mrna1273vaccinationacasereportandliteraturereview

Ejemplares similares